(IBDQ) iShares iBonds Dec 2025 - Ratings and Ratios
Bond, Corporate, ETF, ShortTerm, USD
Description: IBDQ iShares iBonds Dec 2025 August 03, 2025
The iShares iBonds Dec 2025 Term Corporate ETF (IBDQ) is a target maturity ETF that invests in a portfolio of U.S. dollar-denominated, investment-grade corporate bonds maturing between January 1, 2025, and December 15, 2025. This ETF provides a diversified exposure to the corporate bond market with a specific maturity date, allowing investors to plan their fixed income investments with precision.
Key characteristics of IBDQ include its investment strategy, which involves holding at least 80% of its assets in the component securities of the underlying index and at least 90% in fixed income securities similar to those in the index. The underlying index is composed of taxable, investment-grade corporate bonds, indicating a focus on high-quality debt securities. With an AUM of $2.943 billion, IBDQ demonstrates a significant presence in the market.
To evaluate the performance of IBDQ, several key performance indicators (KPIs) can be considered. These include the yield to maturity (YTM), which is a crucial metric for bond ETFs as it reflects the total return an investor can expect if the ETF is held until the maturity date of its underlying bonds. Other relevant KPIs are the duration and credit quality of the portfolio, which provide insights into the ETFs sensitivity to interest rate changes and its exposure to credit risk, respectively. Additionally, the expense ratio, which is a measure of the ETFs operational costs relative to its assets, is also an important consideration for investors.
Investors in IBDQ can expect a relatively stable source of income as the ETF matures, with the bonds in the portfolio being held to maturity. This makes IBDQ an attractive option for investors seeking predictable income streams and looking to manage their interest rate risk. The ETFs price movements, as reflected in its technical data, such as SMA20, SMA50, and SMA200, indicate its short-term and long-term trends, which can be used to inform investment decisions.
IBDQ ETF Overview
| Market Cap in USD | 2,752m |
| Category | Target Maturity |
| TER | 0.10% |
| IPO / Inception | 2015-03-11 |
IBDQ ETF Ratings
| Growth Rating | 65.8% |
| Fundamental | - |
| Dividend Rating | 66.8% |
| Return 12m vs S&P 500 | -13.7% |
| Analyst Rating | - |
IBDQ Dividends
| Dividend Yield 12m | 3.73% |
| Yield on Cost 5y | 4.02% |
| Annual Growth 5y | 8.52% |
| Payout Consistency | 94.8% |
| Payout Ratio | % |
IBDQ Growth Ratios
| Growth Correlation 3m | 99.8% |
| Growth Correlation 12m | 100% |
| Growth Correlation 5y | 43.8% |
| CAGR 5y | 5.34% |
| CAGR/Max DD 3y (Calmar Ratio) | 2.94 |
| CAGR/Mean DD 3y (Pain Ratio) | 35.92 |
| Sharpe Ratio 12m | -6.98 |
| Alpha | -2.45 |
| Beta | 0.200 |
| Volatility | 0.85% |
| Current Volume | 1383.9k |
| Average Volume 20d | 432.2k |
| Stop Loss | 24.4 (-3.2%) |
| Signal | 1.07 |
What is the price of IBDQ shares?
Over the past week, the price has changed by +0.08%, over one month by +0.40%, over three months by +1.10% and over the past year by +4.56%.
Is iShares iBonds Dec 2025 a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of IBDQ is around 24.53 USD . This means that IBDQ is currently overvalued and has a potential downside of -2.66%.
Is IBDQ a buy, sell or hold?
What are the forecasts/targets for the IBDQ price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 26.9 | 6.8% |
IBDQ Fundamental Data Overview October 30, 2025
Beta = 0.2
Revenue TTM = 0.0 USD
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 2.75b USD (2.75b + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 2.75b)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 2.75b / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 6.75% (E(2.75b)/V(2.75b) * Re(6.75%) + (debt-free company))
Discount Rate = 6.75% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Fair Price DCF = unknown (Cash Flow 0.0)
Additional Sources for IBDQ ETF
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle